Quotes 5-day view Delayed Euronext Amsterdam
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
138.95(c)
140.35(c)
137.1(c)
137.2(c)
137.45(c)
Last
319 307
292 836
419 113
438 337
407 609
Volume
-1.66% +1.01% -2.32% +0.07% +0.18% Change
Sales 2020
8 924 M 10 392 M 10 392 M
Net income 2020
692 M 805 M 805 M
Net Debt 2020
2 793 M 3 253 M 3 253 M
P/E ratio 2020
34,6x
Yield 2020
1,81%
Sales 2021
9 466 M 11 023 M 11 023 M
Net income 2021
881 M 1 025 M 1 025 M
Net Debt 2021
2 186 M 2 546 M 2 546 M
P/E ratio 2021
26,4x
Yield 2021
1,88%
Capitalization
23 308 M 27 162 M 27 142 M
EV / Sales 2020
2,92x
EV / Sales 2021
2,69x
Nbr of Employees
21 940
Free-Float
94,7%
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by...
Notations Surperformance© of Royal DSM N.V.
Trading Rating : Investor Rating :
All news about ROYAL DSM N.V.
News in other languages on ROYAL DSM N.V.
What is the science behind the moo-ve from cattle methane emissions?
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ROYAL DSM N.V.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
24
Average target price
143,44 €
Last Close Price
137,45 €
Spread / Highest target
25,1%
Spread / Average Target
4,36%
Spread / Lowest Target
-43,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
